Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus | 45 | 2022 | 530 | 9.260 |
Why?
|
Hypoglycemic Agents | 23 | 2021 | 288 | 3.900 |
Why?
|
Diabetes Mellitus, Type 2 | 23 | 2022 | 760 | 3.610 |
Why?
|
Medication Adherence | 23 | 2020 | 267 | 3.300 |
Why?
|
Prediabetic State | 6 | 2019 | 53 | 2.640 |
Why?
|
Humans | 138 | 2023 | 18430 | 2.450 |
Why?
|
Postal Service | 7 | 2020 | 83 | 2.300 |
Why?
|
Hypertension | 20 | 2019 | 524 | 2.270 |
Why?
|
Physician-Patient Relations | 15 | 2017 | 197 | 2.090 |
Why?
|
Cardiovascular Diseases | 14 | 2021 | 630 | 2.060 |
Why?
|
Delivery of Health Care, Integrated | 7 | 2023 | 567 | 2.030 |
Why?
|
Antihypertensive Agents | 15 | 2015 | 172 | 1.990 |
Why?
|
California | 46 | 2023 | 2365 | 1.950 |
Why?
|
Telephone | 8 | 2017 | 179 | 1.930 |
Why?
|
Female | 95 | 2022 | 13136 | 1.910 |
Why?
|
Patient Compliance | 11 | 2014 | 318 | 1.810 |
Why?
|
Adult | 67 | 2023 | 7910 | 1.780 |
Why?
|
Male | 81 | 2021 | 10440 | 1.760 |
Why?
|
Retrospective Studies | 32 | 2023 | 2550 | 1.690 |
Why?
|
Pharmaceutical Services | 5 | 2019 | 37 | 1.670 |
Why?
|
Blood Glucose | 9 | 2022 | 346 | 1.670 |
Why?
|
Aged | 62 | 2021 | 6417 | 1.670 |
Why?
|
Health Promotion | 10 | 2017 | 294 | 1.590 |
Why?
|
Middle Aged | 70 | 2021 | 8284 | 1.510 |
Why?
|
Quality Improvement | 6 | 2017 | 207 | 1.340 |
Why?
|
United States | 41 | 2022 | 4164 | 1.300 |
Why?
|
Delivery of Health Care | 6 | 2020 | 444 | 1.300 |
Why?
|
Glycated Hemoglobin A | 14 | 2022 | 233 | 1.300 |
Why?
|
Health Maintenance Organizations | 16 | 2013 | 479 | 1.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 182 | 1.260 |
Why?
|
Insurance, Pharmaceutical Services | 5 | 2014 | 27 | 1.240 |
Why?
|
Quality of Health Care | 10 | 2020 | 347 | 1.180 |
Why?
|
Aged, 80 and over | 22 | 2021 | 2003 | 1.140 |
Why?
|
Mentoring | 2 | 2017 | 28 | 1.110 |
Why?
|
Healthcare Disparities | 3 | 2020 | 211 | 1.100 |
Why?
|
Patient-Centered Care | 6 | 2016 | 228 | 1.050 |
Why?
|
Primary Health Care | 14 | 2017 | 848 | 1.030 |
Why?
|
Chronic Disease | 12 | 2010 | 468 | 1.020 |
Why?
|
Practice Patterns, Physicians' | 10 | 2017 | 350 | 1.000 |
Why?
|
Occupational Health Services | 2 | 2015 | 16 | 0.950 |
Why?
|
Medicare Part D | 5 | 2010 | 21 | 0.950 |
Why?
|
Cross-Sectional Studies | 19 | 2015 | 1360 | 0.900 |
Why?
|
Medicare | 2 | 2015 | 214 | 0.900 |
Why?
|
Health Services Research | 12 | 2019 | 264 | 0.860 |
Why?
|
Adolescent | 21 | 2023 | 3798 | 0.860 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 57 | 0.850 |
Why?
|
Feeding and Eating Disorders | 1 | 2022 | 17 | 0.850 |
Why?
|
Health Priorities | 3 | 2019 | 28 | 0.850 |
Why?
|
Leadership | 2 | 2022 | 45 | 0.840 |
Why?
|
Delayed Diagnosis | 2 | 2020 | 19 | 0.840 |
Why?
|
Risk Factors | 23 | 2021 | 3449 | 0.840 |
Why?
|
Electronic Health Records | 10 | 2018 | 747 | 0.830 |
Why?
|
Comparative Effectiveness Research | 4 | 2015 | 77 | 0.820 |
Why?
|
Patient Satisfaction | 12 | 2017 | 232 | 0.820 |
Why?
|
Program Evaluation | 7 | 2015 | 244 | 0.760 |
Why?
|
Managed Care Programs | 6 | 2010 | 347 | 0.750 |
Why?
|
Uterine Hemorrhage | 1 | 2020 | 9 | 0.740 |
Why?
|
Logistic Models | 17 | 2019 | 962 | 0.740 |
Why?
|
Health Services Accessibility | 6 | 2022 | 320 | 0.740 |
Why?
|
Pharmacy | 1 | 2020 | 12 | 0.730 |
Why?
|
Patient Acceptance of Health Care | 4 | 2015 | 407 | 0.730 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 39 | 0.730 |
Why?
|
European Continental Ancestry Group | 5 | 2020 | 554 | 0.720 |
Why?
|
Outcome and Process Assessment (Health Care) | 7 | 2016 | 110 | 0.720 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2020 | 124 | 0.690 |
Why?
|
Mental Disorders | 2 | 2020 | 295 | 0.690 |
Why?
|
Physicians, Family | 6 | 2004 | 47 | 0.690 |
Why?
|
Coronavirus Infections | 1 | 2020 | 50 | 0.680 |
Why?
|
Health Services for the Aged | 1 | 2019 | 15 | 0.680 |
Why?
|
Women's Health | 3 | 2022 | 207 | 0.680 |
Why?
|
Pandemics | 2 | 2020 | 292 | 0.650 |
Why?
|
Smoking Cessation | 2 | 2020 | 199 | 0.650 |
Why?
|
Glycemic Index | 1 | 2018 | 21 | 0.640 |
Why?
|
Medicare Part C | 1 | 2018 | 22 | 0.630 |
Why?
|
Research Personnel | 2 | 2015 | 30 | 0.630 |
Why?
|
Quality Assurance, Health Care | 7 | 2010 | 188 | 0.620 |
Why?
|
Cholesterol, LDL | 6 | 2017 | 125 | 0.620 |
Why?
|
Quality Indicators, Health Care | 9 | 2017 | 197 | 0.610 |
Why?
|
Weight Loss | 3 | 2017 | 321 | 0.600 |
Why?
|
Outcome Assessment (Health Care) | 6 | 2016 | 254 | 0.600 |
Why?
|
Asian Continental Ancestry Group | 2 | 2020 | 90 | 0.590 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2018 | 51 | 0.590 |
Why?
|
Hyperlipidemias | 5 | 2011 | 58 | 0.590 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2017 | 90 | 0.580 |
Why?
|
Insurance Coverage | 4 | 2010 | 136 | 0.570 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2017 | 53 | 0.570 |
Why?
|
Incidence | 9 | 2022 | 1314 | 0.560 |
Why?
|
Blood Pressure | 11 | 2017 | 310 | 0.560 |
Why?
|
Drug Costs | 4 | 2013 | 40 | 0.560 |
Why?
|
Prescription Drugs | 2 | 2014 | 33 | 0.550 |
Why?
|
Health Policy | 5 | 2017 | 136 | 0.550 |
Why?
|
Comorbidity | 7 | 2019 | 619 | 0.550 |
Why?
|
Motivational Interviewing | 1 | 2016 | 32 | 0.550 |
Why?
|
Patient Participation | 3 | 2016 | 144 | 0.540 |
Why?
|
Mass Media | 1 | 2015 | 17 | 0.530 |
Why?
|
Health Care Surveys | 8 | 2017 | 247 | 0.530 |
Why?
|
Depression | 5 | 2015 | 518 | 0.520 |
Why?
|
Treatment Outcome | 12 | 2017 | 1296 | 0.510 |
Why?
|
Young Adult | 17 | 2021 | 2518 | 0.510 |
Why?
|
Electronic Mail | 1 | 2015 | 53 | 0.510 |
Why?
|
Total Quality Management | 2 | 2017 | 27 | 0.510 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 526 | 0.500 |
Why?
|
Obesity | 4 | 2017 | 855 | 0.500 |
Why?
|
Physicians, Women | 4 | 2009 | 10 | 0.500 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 382 | 0.490 |
Why?
|
Translational Medical Research | 2 | 2015 | 39 | 0.470 |
Why?
|
Contraception | 4 | 2018 | 25 | 0.470 |
Why?
|
Esophageal Neoplasms | 3 | 2010 | 116 | 0.470 |
Why?
|
Barrett Esophagus | 3 | 2010 | 114 | 0.460 |
Why?
|
Insurance Claim Review | 6 | 2020 | 70 | 0.460 |
Why?
|
Diabetes, Gestational | 4 | 2015 | 339 | 0.440 |
Why?
|
Cohort Studies | 10 | 2020 | 2672 | 0.440 |
Why?
|
Employee Incentive Plans | 1 | 2013 | 4 | 0.430 |
Why?
|
Life Style | 6 | 2019 | 342 | 0.430 |
Why?
|
Pharmacies | 2 | 2015 | 10 | 0.420 |
Why?
|
Choice Behavior | 7 | 2016 | 48 | 0.410 |
Why?
|
African Continental Ancestry Group | 1 | 2013 | 166 | 0.410 |
Why?
|
Disease Management | 4 | 2006 | 143 | 0.400 |
Why?
|
Health Behavior | 2 | 2013 | 374 | 0.400 |
Why?
|
Family Planning Services | 3 | 2016 | 27 | 0.390 |
Why?
|
Patient Care Management | 2 | 2009 | 32 | 0.390 |
Why?
|
Communication | 6 | 2016 | 202 | 0.390 |
Why?
|
Self Care | 3 | 2007 | 175 | 0.390 |
Why?
|
Provider-Sponsored Organizations | 3 | 2005 | 3 | 0.380 |
Why?
|
Counseling | 4 | 2017 | 197 | 0.380 |
Why?
|
Systems Theory | 1 | 2010 | 3 | 0.360 |
Why?
|
Ambulatory Care Facilities | 1 | 2011 | 77 | 0.360 |
Why?
|
Diabetes Complications | 5 | 2021 | 119 | 0.360 |
Why?
|
Race Relations | 1 | 2009 | 1 | 0.350 |
Why?
|
Hawaii | 2 | 2020 | 45 | 0.350 |
Why?
|
African Americans | 4 | 2020 | 490 | 0.350 |
Why?
|
Community-Based Participatory Research | 1 | 2010 | 63 | 0.340 |
Why?
|
Needs Assessment | 2 | 2020 | 69 | 0.340 |
Why?
|
Risk Reduction Behavior | 3 | 2015 | 114 | 0.330 |
Why?
|
Multivariate Analysis | 10 | 2015 | 598 | 0.330 |
Why?
|
Treatment Refusal | 2 | 2008 | 38 | 0.320 |
Why?
|
Registries | 5 | 2012 | 490 | 0.300 |
Why?
|
Body Mass Index | 6 | 2017 | 974 | 0.300 |
Why?
|
Guideline Adherence | 2 | 2010 | 162 | 0.300 |
Why?
|
Adenocarcinoma | 2 | 2010 | 177 | 0.300 |
Why?
|
Contraception Behavior | 3 | 2016 | 15 | 0.290 |
Why?
|
Socioeconomic Factors | 5 | 2016 | 673 | 0.290 |
Why?
|
Accountable Care Organizations | 2 | 2017 | 4 | 0.290 |
Why?
|
Models, Statistical | 4 | 2018 | 185 | 0.290 |
Why?
|
Quality-Adjusted Life Years | 1 | 2007 | 41 | 0.290 |
Why?
|
Pregnancy | 7 | 2018 | 1516 | 0.290 |
Why?
|
Ethnic Groups | 5 | 2020 | 501 | 0.290 |
Why?
|
Cost Sharing | 2 | 2018 | 40 | 0.280 |
Why?
|
Gynecology | 3 | 2011 | 23 | 0.270 |
Why?
|
Qualitative Research | 5 | 2019 | 272 | 0.270 |
Why?
|
Professional-Patient Relations | 3 | 2016 | 48 | 0.270 |
Why?
|
Odds Ratio | 5 | 2015 | 701 | 0.260 |
Why?
|
Hispanic Americans | 3 | 2020 | 428 | 0.260 |
Why?
|
Sex Factors | 5 | 2015 | 661 | 0.260 |
Why?
|
Preventive Health Services | 2 | 2004 | 166 | 0.260 |
Why?
|
Time Factors | 8 | 2021 | 1136 | 0.250 |
Why?
|
Propensity Score | 2 | 2016 | 94 | 0.250 |
Why?
|
Monitoring, Physiologic | 2 | 2015 | 41 | 0.250 |
Why?
|
Prevalence | 2 | 2020 | 911 | 0.240 |
Why?
|
Follow-Up Studies | 7 | 2021 | 1269 | 0.240 |
Why?
|
Efficiency, Organizational | 3 | 2017 | 36 | 0.240 |
Why?
|
Decision Making | 2 | 2017 | 204 | 0.230 |
Why?
|
Gastroesophageal Reflux | 3 | 2009 | 79 | 0.230 |
Why?
|
Adiposity | 1 | 2014 | 67 | 0.230 |
Why?
|
Reminder Systems | 1 | 2004 | 94 | 0.230 |
Why?
|
Quality of Life | 3 | 2016 | 529 | 0.230 |
Why?
|
Patient Care Team | 4 | 2012 | 127 | 0.220 |
Why?
|
Health Care Reform | 2 | 2015 | 33 | 0.220 |
Why?
|
Housing | 1 | 2023 | 40 | 0.210 |
Why?
|
Databases, Factual | 5 | 2015 | 327 | 0.210 |
Why?
|
Surveys and Questionnaires | 10 | 2016 | 1389 | 0.210 |
Why?
|
Algorithms | 2 | 2014 | 241 | 0.210 |
Why?
|
Risk | 2 | 2020 | 552 | 0.210 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2015 | 180 | 0.210 |
Why?
|
Insulin | 3 | 2020 | 208 | 0.210 |
Why?
|
Attitude to Health | 2 | 2004 | 177 | 0.210 |
Why?
|
Models, Organizational | 3 | 2013 | 65 | 0.210 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 159 | 0.210 |
Why?
|
Dietary Fiber | 2 | 2010 | 60 | 0.210 |
Why?
|
Contraceptive Agents | 3 | 2018 | 7 | 0.210 |
Why?
|
Hypolipidemic Agents | 4 | 2010 | 44 | 0.200 |
Why?
|
Group Practice | 4 | 2005 | 26 | 0.200 |
Why?
|
Insulin, Short-Acting | 1 | 2021 | 3 | 0.200 |
Why?
|
Precancerous Conditions | 2 | 2009 | 48 | 0.200 |
Why?
|
Insulin, Long-Acting | 1 | 2021 | 12 | 0.200 |
Why?
|
Independent Practice Associations | 4 | 2005 | 8 | 0.200 |
Why?
|
Focus Groups | 2 | 2019 | 154 | 0.200 |
Why?
|
Yoga | 1 | 2011 | 26 | 0.190 |
Why?
|
Remote Consultation | 1 | 2020 | 11 | 0.190 |
Why?
|
Fear | 1 | 2020 | 13 | 0.190 |
Why?
|
RNA, Viral | 1 | 2020 | 64 | 0.190 |
Why?
|
Communicable Disease Control | 1 | 2020 | 19 | 0.180 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 52 | 0.180 |
Why?
|
Micronutrients | 1 | 2010 | 9 | 0.180 |
Why?
|
Time-to-Treatment | 1 | 2020 | 18 | 0.180 |
Why?
|
Hypokalemia | 1 | 2020 | 3 | 0.180 |
Why?
|
Betacoronavirus | 1 | 2020 | 36 | 0.180 |
Why?
|
Clinical Competence | 3 | 2010 | 108 | 0.180 |
Why?
|
Diet | 2 | 2014 | 371 | 0.180 |
Why?
|
Insulin, Regular, Human | 1 | 2020 | 5 | 0.180 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2020 | 4 | 0.180 |
Why?
|
Hyperkalemia | 1 | 2020 | 17 | 0.180 |
Why?
|
Patient Admission | 2 | 2019 | 76 | 0.180 |
Why?
|
Heart Failure | 4 | 2020 | 398 | 0.170 |
Why?
|
Age Factors | 3 | 2018 | 965 | 0.170 |
Why?
|
Syncope | 1 | 2019 | 12 | 0.170 |
Why?
|
Social Work | 1 | 2019 | 13 | 0.170 |
Why?
|
Drug Therapy | 2 | 2009 | 21 | 0.170 |
Why?
|
Women | 1 | 1999 | 12 | 0.170 |
Why?
|
Nurse Practitioners | 1 | 1999 | 20 | 0.170 |
Why?
|
Child | 2 | 2022 | 2571 | 0.170 |
Why?
|
Meat | 1 | 2009 | 27 | 0.160 |
Why?
|
Hypoglycemia | 1 | 2019 | 49 | 0.160 |
Why?
|
Hip Fractures | 1 | 2019 | 68 | 0.160 |
Why?
|
Motor Activity | 3 | 2015 | 215 | 0.160 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 109 | 0.160 |
Why?
|
Dietary Fats | 1 | 2009 | 92 | 0.160 |
Why?
|
Colorado | 2 | 2017 | 211 | 0.160 |
Why?
|
Administration, Oral | 1 | 2018 | 86 | 0.160 |
Why?
|
Physician's Role | 3 | 2017 | 32 | 0.160 |
Why?
|
Hospitalization | 3 | 2022 | 847 | 0.160 |
Why?
|
Pharmacists | 3 | 2014 | 48 | 0.150 |
Why?
|
Pilot Projects | 2 | 2013 | 237 | 0.150 |
Why?
|
Spouses | 1 | 2017 | 10 | 0.150 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2016 | 392 | 0.150 |
Why?
|
Work Performance | 1 | 2017 | 1 | 0.150 |
Why?
|
Employee Performance Appraisal | 1 | 2017 | 6 | 0.150 |
Why?
|
Social Support | 3 | 2019 | 214 | 0.140 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 56 | 0.140 |
Why?
|
Disclosure | 1 | 2016 | 19 | 0.140 |
Why?
|
Deductibles and Coinsurance | 2 | 2014 | 31 | 0.140 |
Why?
|
Diabetic Neuropathies | 1 | 2016 | 13 | 0.130 |
Why?
|
Office Visits | 1 | 2016 | 86 | 0.130 |
Why?
|
Patient Reported Outcome Measures | 1 | 2016 | 54 | 0.130 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 74 | 0.130 |
Why?
|
Machine Learning | 1 | 2016 | 44 | 0.130 |
Why?
|
Longitudinal Studies | 4 | 2018 | 724 | 0.130 |
Why?
|
Neoplasms | 1 | 2020 | 457 | 0.130 |
Why?
|
Glucose Tolerance Test | 1 | 2015 | 106 | 0.130 |
Why?
|
Smoking | 1 | 2008 | 494 | 0.130 |
Why?
|
Career Mobility | 1 | 2015 | 6 | 0.130 |
Why?
|
Research Support as Topic | 1 | 2015 | 23 | 0.130 |
Why?
|
Interprofessional Relations | 1 | 2015 | 25 | 0.130 |
Why?
|
Data Interpretation, Statistical | 2 | 2014 | 83 | 0.130 |
Why?
|
Self Report | 2 | 2015 | 256 | 0.130 |
Why?
|
Postpartum Period | 1 | 2015 | 93 | 0.120 |
Why?
|
Asian Americans | 2 | 2010 | 182 | 0.120 |
Why?
|
Safety-net Providers | 1 | 2015 | 63 | 0.120 |
Why?
|
Social Networking | 1 | 2014 | 20 | 0.120 |
Why?
|
Drug Utilization | 1 | 2015 | 134 | 0.120 |
Why?
|
Patient Education as Topic | 3 | 2014 | 214 | 0.120 |
Why?
|
Social Environment | 1 | 2014 | 90 | 0.120 |
Why?
|
Diabetic Nephropathies | 1 | 2014 | 28 | 0.120 |
Why?
|
Behavior Therapy | 1 | 2015 | 155 | 0.120 |
Why?
|
Health Systems Plans | 1 | 2013 | 4 | 0.120 |
Why?
|
Physician Incentive Plans | 2 | 2004 | 9 | 0.120 |
Why?
|
Vital Signs | 1 | 2013 | 14 | 0.120 |
Why?
|
Trust | 3 | 2009 | 31 | 0.120 |
Why?
|
Blood Pressure Determination | 2 | 2011 | 58 | 0.120 |
Why?
|
Early Medical Intervention | 1 | 2013 | 10 | 0.110 |
Why?
|
Medicaid | 1 | 2015 | 211 | 0.110 |
Why?
|
Insurance, Health | 1 | 2015 | 217 | 0.110 |
Why?
|
Mass Screening | 2 | 2013 | 690 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2013 | 21 | 0.110 |
Why?
|
Primary Prevention | 2 | 2012 | 79 | 0.110 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 226 | 0.110 |
Why?
|
State Health Plans | 1 | 2013 | 44 | 0.110 |
Why?
|
Glucose Intolerance | 1 | 2013 | 45 | 0.110 |
Why?
|
Cooperative Behavior | 2 | 2010 | 102 | 0.110 |
Why?
|
Obstetrics | 2 | 2011 | 23 | 0.110 |
Why?
|
Cerebrovascular Disorders | 1 | 2012 | 35 | 0.100 |
Why?
|
Drug Resistance | 1 | 2012 | 30 | 0.100 |
Why?
|
Weight Gain | 1 | 2014 | 181 | 0.100 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 333 | 0.100 |
Why?
|
Anxiety | 1 | 2012 | 156 | 0.100 |
Why?
|
Research Design | 4 | 2016 | 402 | 0.100 |
Why?
|
Coronary Disease | 1 | 2012 | 185 | 0.090 |
Why?
|
Electronic Prescribing | 1 | 2010 | 6 | 0.090 |
Why?
|
Drugs, Generic | 1 | 2010 | 5 | 0.090 |
Why?
|
Cost Control | 1 | 2010 | 25 | 0.090 |
Why?
|
Reimbursement, Incentive | 1 | 2010 | 31 | 0.090 |
Why?
|
Health Care Costs | 4 | 2015 | 251 | 0.090 |
Why?
|
Fees, Pharmaceutical | 1 | 2009 | 2 | 0.090 |
Why?
|
Language | 1 | 2010 | 52 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 160 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2010 | 36 | 0.090 |
Why?
|
Reimbursement Mechanisms | 1 | 2009 | 20 | 0.090 |
Why?
|
Depressive Disorder | 1 | 2012 | 231 | 0.090 |
Why?
|
Research | 1 | 2010 | 73 | 0.090 |
Why?
|
Causality | 1 | 2009 | 43 | 0.090 |
Why?
|
Patients | 1 | 2009 | 38 | 0.090 |
Why?
|
Specialization | 2 | 1999 | 26 | 0.080 |
Why?
|
Observation | 1 | 2009 | 25 | 0.080 |
Why?
|
Diabetic Retinopathy | 2 | 2010 | 19 | 0.080 |
Why?
|
Patient Care | 1 | 2009 | 36 | 0.080 |
Why?
|
Social Class | 1 | 2009 | 125 | 0.080 |
Why?
|
Exercise | 1 | 2013 | 495 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2015 | 96 | 0.080 |
Why?
|
Confounding Factors (Epidemiology) | 3 | 2014 | 99 | 0.080 |
Why?
|
Peptic Ulcer | 2 | 1998 | 14 | 0.080 |
Why?
|
Medical Audit | 1 | 2008 | 41 | 0.080 |
Why?
|
Health Facility Administration | 1 | 2007 | 2 | 0.080 |
Why?
|
Decision Making, Organizational | 1 | 2007 | 4 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 16 | 0.070 |
Why?
|
Overweight | 2 | 2014 | 276 | 0.070 |
Why?
|
Mammography | 2 | 2010 | 174 | 0.070 |
Why?
|
Multicenter Studies as Topic | 3 | 2014 | 91 | 0.070 |
Why?
|
Health Surveys | 1 | 2007 | 269 | 0.070 |
Why?
|
Ambulatory Care | 4 | 2010 | 266 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2009 | 1173 | 0.060 |
Why?
|
Practice Management, Medical | 1 | 2005 | 17 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2005 | 71 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 743 | 0.060 |
Why?
|
Information Services | 1 | 2004 | 18 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2014 | 60 | 0.060 |
Why?
|
Albuminuria | 2 | 2014 | 41 | 0.060 |
Why?
|
Computer Simulation | 2 | 2014 | 85 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2006 | 476 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2010 | 399 | 0.060 |
Why?
|
Clinical Protocols | 2 | 2016 | 45 | 0.060 |
Why?
|
Linear Models | 2 | 2017 | 243 | 0.060 |
Why?
|
Information Systems | 1 | 2003 | 23 | 0.050 |
Why?
|
Prospective Studies | 3 | 2016 | 1314 | 0.050 |
Why?
|
Interviews as Topic | 2 | 2008 | 327 | 0.050 |
Why?
|
Medicine | 2 | 1999 | 23 | 0.050 |
Why?
|
Benchmarking | 2 | 2017 | 45 | 0.050 |
Why?
|
Women, Working | 1 | 2002 | 6 | 0.050 |
Why?
|
Influenza, Human | 1 | 2004 | 282 | 0.050 |
Why?
|
Medically Underserved Area | 1 | 2011 | 17 | 0.050 |
Why?
|
Immunocompromised Host | 1 | 2020 | 20 | 0.050 |
Why?
|
Risk Assessment | 1 | 2005 | 1143 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2011 | 120 | 0.050 |
Why?
|
Fruit | 1 | 2010 | 79 | 0.040 |
Why?
|
Vegetables | 1 | 2010 | 87 | 0.040 |
Why?
|
Potassium | 1 | 2020 | 17 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2020 | 95 | 0.040 |
Why?
|
Financing, Personal | 2 | 2010 | 24 | 0.040 |
Why?
|
Anticoagulants | 1 | 2020 | 125 | 0.040 |
Why?
|
Economics, Medical | 1 | 1999 | 6 | 0.040 |
Why?
|
Disease Progression | 1 | 2010 | 271 | 0.040 |
Why?
|
Trans Fatty Acids | 1 | 2009 | 4 | 0.040 |
Why?
|
Cooking | 1 | 2009 | 17 | 0.040 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2009 | 22 | 0.040 |
Why?
|
United States Department of Veterans Affairs | 2 | 2010 | 126 | 0.040 |
Why?
|
Geography | 1 | 2008 | 41 | 0.040 |
Why?
|
Health Expenditures | 2 | 2010 | 82 | 0.040 |
Why?
|
Helicobacter Infections | 1 | 1998 | 22 | 0.040 |
Why?
|
Helicobacter pylori | 1 | 1998 | 24 | 0.040 |
Why?
|
Animals | 1 | 2009 | 261 | 0.040 |
Why?
|
Drug Prescriptions | 2 | 2010 | 157 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2008 | 253 | 0.040 |
Why?
|
Gastritis | 1 | 1997 | 2 | 0.040 |
Why?
|
Dyspepsia | 1 | 1997 | 5 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 249 | 0.040 |
Why?
|
Workflow | 1 | 2017 | 11 | 0.040 |
Why?
|
Checklist | 1 | 2016 | 15 | 0.040 |
Why?
|
Stroke | 1 | 2020 | 311 | 0.040 |
Why?
|
Patient Safety | 1 | 2017 | 41 | 0.040 |
Why?
|
Hospitals | 1 | 1997 | 80 | 0.030 |
Why?
|
San Francisco | 1 | 2016 | 68 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2004 | 1037 | 0.030 |
Why?
|
Regression Analysis | 3 | 2004 | 319 | 0.030 |
Why?
|
Automation | 1 | 2016 | 24 | 0.030 |
Why?
|
Aging | 1 | 1997 | 165 | 0.030 |
Why?
|
Pregnancy, High-Risk | 1 | 1995 | 4 | 0.030 |
Why?
|
Fetal Death | 1 | 1995 | 10 | 0.030 |
Why?
|
Maternal Age | 1 | 1995 | 80 | 0.030 |
Why?
|
Public Health | 1 | 2016 | 82 | 0.030 |
Why?
|
Epidemiologic Factors | 1 | 2015 | 4 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2008 | 375 | 0.030 |
Why?
|
Tape Recording | 1 | 2014 | 6 | 0.030 |
Why?
|
Information Seeking Behavior | 1 | 2014 | 11 | 0.030 |
Why?
|
Biostatistics | 1 | 2014 | 10 | 0.030 |
Why?
|
Selection Bias | 1 | 2014 | 24 | 0.030 |
Why?
|
Probability | 1 | 2014 | 86 | 0.030 |
Why?
|
Observational Studies as Topic | 1 | 2014 | 49 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2017 | 256 | 0.030 |
Why?
|
Creatinine | 1 | 2014 | 65 | 0.030 |
Why?
|
Poverty | 1 | 2015 | 182 | 0.030 |
Why?
|
Postnatal Care | 1 | 2014 | 22 | 0.030 |
Why?
|
Directive Counseling | 1 | 2014 | 25 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 119 | 0.030 |
Why?
|
Epidemiological Monitoring | 1 | 2013 | 27 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2014 | 157 | 0.030 |
Why?
|
Sulfonylurea Compounds | 1 | 2013 | 28 | 0.030 |
Why?
|
Diffusion of Innovation | 2 | 2004 | 44 | 0.030 |
Why?
|
Data Collection | 2 | 2007 | 275 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2013 | 11 | 0.030 |
Why?
|
Fasting | 1 | 2013 | 48 | 0.030 |
Why?
|
Self Efficacy | 1 | 2013 | 71 | 0.030 |
Why?
|
Metformin | 1 | 2013 | 61 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2013 | 76 | 0.030 |
Why?
|
Community Health Workers | 1 | 2012 | 15 | 0.030 |
Why?
|
Diuretics | 1 | 2012 | 17 | 0.030 |
Why?
|
Prenatal Care | 1 | 2014 | 134 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 43 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 131 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 270 | 0.020 |
Why?
|
Veterans | 1 | 2012 | 138 | 0.020 |
Why?
|
Age of Onset | 1 | 2010 | 82 | 0.020 |
Why?
|
Frustration | 1 | 2010 | 2 | 0.020 |
Why?
|
Multilingualism | 1 | 2010 | 8 | 0.020 |
Why?
|
Insurance, Medigap | 1 | 2009 | 2 | 0.020 |
Why?
|
Demography | 1 | 2010 | 108 | 0.020 |
Why?
|
Systole | 1 | 2009 | 22 | 0.020 |
Why?
|
Biomarkers | 1 | 2010 | 308 | 0.020 |
Why?
|
Asthma | 2 | 2003 | 390 | 0.020 |
Why?
|
Physicians | 1 | 2010 | 141 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2010 | 127 | 0.020 |
Why?
|
Continental Population Groups | 1 | 2010 | 315 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 95 | 0.020 |
Why?
|
Empirical Research | 1 | 2005 | 2 | 0.020 |
Why?
|
Financial Management | 1 | 2005 | 3 | 0.020 |
Why?
|
Organizational Culture | 1 | 2005 | 18 | 0.020 |
Why?
|
Learning | 1 | 2005 | 10 | 0.020 |
Why?
|
Information Dissemination | 1 | 2004 | 57 | 0.010 |
Why?
|
Perception | 1 | 2003 | 59 | 0.010 |
Why?
|
Case Management | 1 | 2002 | 37 | 0.010 |
Why?
|
Medical Informatics | 1 | 2002 | 45 | 0.010 |
Why?
|
England | 1 | 2002 | 4 | 0.010 |
Why?
|
Efficiency | 1 | 2002 | 13 | 0.010 |
Why?
|
Australia | 1 | 2002 | 23 | 0.010 |
Why?
|
Canada | 1 | 2002 | 67 | 0.010 |
Why?
|
Family Practice | 1 | 2002 | 53 | 0.010 |
Why?
|
Workload | 1 | 2002 | 30 | 0.010 |
Why?
|
Internship and Residency | 1 | 2002 | 50 | 0.010 |
Why?
|
Health Facility Environment | 1 | 1999 | 2 | 0.010 |
Why?
|
Poisson Distribution | 1 | 1999 | 94 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1998 | 89 | 0.010 |
Why?
|
Referral and Consultation | 1 | 1999 | 180 | 0.010 |
Why?
|
Quebec | 1 | 1995 | 2 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 1995 | 17 | 0.010 |
Why?
|
Infant Mortality | 1 | 1995 | 22 | 0.010 |
Why?
|
Parity | 1 | 1995 | 74 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1995 | 193 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1995 | 872 | 0.010 |
Why?
|